Evaluation of Some Physiological Parameters of Spontaneous Abortion Patients in Karbala Government

Jaafar Subaih  Awad; Abdullah Salam  Hassan; Mohammed Ahmed  Hussein; Haydar Reda  Fleih; Esraa Thamer  Mousa; Zahraa Chasib  Hameed; Zahraa  Hahi

Jaafar Subaih Awad College of Applied Medical Sciences, Department of Environmental Health, University of Karbala, Karbala, Iraq
Abdullah Salam Hassan College of Applied Medical Sciences, Department of Environmental Health, University of Karbala, Karbala, Iraq
Mohammed Ahmed Hussein College of Applied Medical Sciences, Department of Environmental Health, University of Karbala, Karbala, Iraq
Haydar Reda Fleih College of Applied Medical Sciences, Department of Environmental Health, University of Karbala, Karbala, Iraq
Esraa Thamer Mousa College of Applied Medical Sciences, Department of Environmental Health, University of Karbala, Karbala, Iraq
Zahraa Chasib Hameed College of Applied Medical Sciences, Department of Environmental Health, University of Karbala, Karbala, Iraq
Zahraa Hahi College of Applied Medical Sciences, Department of Environmental Health, University of Karbala, Karbala, Iraq

Keywords: Progesterone, avB3, E-Cadherin, Spontaneous Abortion

Abstract

Spontaneous abortion (SA), a common complication of early pregnancy, is influenced by various hormonal and biochemical factors, yet the precise mechanisms remain poorly understood. This study aimed to investigate the hormonal and biochemical factors associated with SA, addressing the need for a deeper understanding of these associations. A case-control study was conducted between November 2023 and February 2024, involving a purposeful sample of seventy women diagnosed with SA, recruited from fertility centers and the Gynecology and Obstetrics Teaching Hospital in Karbala province, Iraq. Data collection involved an interview-based questionnaire covering personal, menstrual, obstetrical, medical history, and other potential risk factors, along with blood samples from both the SA group and healthy controls. The results revealed no significant differences in demographic characteristics between the SA and control groups (p > 0.05). However, significant reductions in progesterone, avB3, and E-Cadherin levels were observed in the SA group compared to the controls (p < 0.05). Additionally, a positive correlation was identified between progesterone and E-Cadherin (r = 0.072 and r = 0.34, respectively), and between avB3 and E-Cadherin (r = 0.324). These findings suggest that decreased levels of progesterone and avB3, along with an altered concentration of E-Cadherin, are strongly associated with SA and may contribute to its occurrence. This study highlights the potential role of these hormonal and biochemical markers in the pathogenesis of SA, offering insights that could inform future diagnostic and therapeutic strategies aimed at reducing the risk of SA.

References

[1] H. Zhou, Y. Liu, L. Liu, M. Zhang, X. Chen, and Y. Qi, "Maternal Pre-Pregnancy Risk Factors for Miscarriage From a Prevention Perspective: A Cohort Study in China," *Eur. J. Obstet. Gynecol. Reprod. Biol.*, vol. 206, pp. 57-63, 2016.
[2] L. Kolatorova, J. Vitku, J. Suchopar, M. Hill, and A. Parizek, "Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine," *Int. J. Mol. Sci.*, vol. 23, no. 14, p. 7989, 2022.
[3] R. Rahnama, M. Rafiee, S. Fouladi, M. Akbari-Fakhrabadi, F. Mehrabian, and A. Rezaei, "Gene Expression Analysis of Membrane Progesterone Receptors in Women with Recurrent Spontaneous Abortion: A Case Control Study," *BMC Res. Notes*, vol. 12, no. 1, pp. 1-5, 2019.
[4] R. Raghupathy and J. Szekeres-Bartho, "Progesterone: A Unique Hormone with Immunomodulatory Roles in Pregnancy," *Int. J. Mol. Sci.*, vol. 23, no. 3, p. 1333, 2022.
[5] G. Xu, Y. Wu, L. Yang, L. Yuan, H. Guo, F. Zhang, Y. Guan, and W. Yao, "Risk Factors for Early Miscarriage Among Chinese: A Hospital-Based Case-Control Study," *Fertil. Steril.*, vol. 101, no. 6, pp. 1663-1670, 2014.
[6] A. P. Mora-Alferez, D. Paredes, O. Rodríguez, E. Quispe, F. Chavesta, E. K. Zighelboim, and M. Michelena, "Anomalías Cromosómicas en Abortos Espontáneos," *Rev. Peru. Ginecol. Obstet.*, vol. 62, no. 2, pp. 141-151, 2016.
[7] J. J. Brittain, S. E. Wahl, J. F. Strauss III, R. Romero, H. M. Wolf, K. Murphy, and T. P. York, "Prior Spontaneous or Induced Abortion Is a Risk Factor for Cervical Dysfunction in Pregnant Women: A Systematic Review and Meta-Analysis," *Reprod. Sci.*, vol. 30, no. 7, pp. 2025-2039, 2023.
[8] J. Liu, Y. Dong, X. Wang, H. Sun, J. Huang, Z. Tang, and H. Sun, "Association of Spontaneous Abortion with Bipolar Disorder and Major Depression Based on Inverse Probability Treatment Weighting of Multigroup Propensity Scores: Evidence from the UK Biobank," *J. Affect. Disord.*, vol. 347, pp. 453-462, 2024.
[9] M. F. E. Diejomaoh, "Recurrent Spontaneous Miscarriage Is Still a Challenging Diagnostic and Therapeutic Quagmire," *Med. Princ. Pract.*, vol. 24, suppl. 1, pp. 38-55, 2015.
[10] J. Dunne, D. Foo, B. A. Dachew, B. Duko, A. T. Gebremedhin, S. D. Nyadanu, and G. A. Tessema, "Diabetic and Hypertensive Disorders Following Early Pregnancy Loss: A Systematic Review and Meta-Analysis," *eClinicalMedicine*, vol. 1, pp. 1-7, 2024.
[11] American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology, "ACOG Practice Bulletin No. 200: Early Pregnancy Loss," *Obstet. Gynecol.*, vol. 132, no. 5, pp. e197-e207, 2018.
[12] K. J. Sapra, K. S. Joseph, S. Galea, L. M. Bates, G. M. B. Louis, and C. V. Ananth, "Signs and Symptoms of Early Pregnancy Loss: A Systematic Review," *Reprod. Sci.*, vol. 24, no. 4, pp. 502-513, 2017.
[13] E. Hendriks, H. MacNaughton, and M. C. MacKenzie, "First Trimester Bleeding: Evaluation and Management," *Am. Fam. Physician*, vol. 99, no. 3, pp. 166-174, 2019.
[14] S. Maraka, N. M. S. Ospina, D. T. O'Keeffe, A. E. Espinosa De Ycaza, M. R. Gionfriddo, P. J. Erwin, and V. M. Montori, "Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis," *Thyroid*, vol. 26, no. 4, pp. 580-590, 2016.
[15] Y. Q. Xiong, J. Tan, Y. M. Liu, Q. He, L. Li, K. Zou, and X. Sun, "The Risk of Maternal Parvovirus B19 Infection During Pregnancy on Fetal Loss and Fetal Hydrops: A Systematic Review and Meta-Analysis," *J. Clin. Virol.*, vol. 114, pp. 12-20, 2019.
[16] T. Frazier, C. J. R. Hogue, E. A. Bonney, K. M. Yount, and B. D. Pearce, "Weathering the Storm; A Review of Pre-Pregnancy Stress and Risk of Spontaneous Abortion," *Psychoneuroendocrinology*, vol. 92, pp. 142-154, 2018.
[17] L. S. Benson, S. K. Holt, J. L. Gore, L. S. Callegari, A. K. Chipman, L. Kessler, and V. K. Dalton, "Early Pregnancy Loss Management in the Emergency Department vs Outpatient Setting," *JAMA Netw. Open*, vol. 6, no. 3, p. e232639, 2023.
[18] X. Y. Wang, S. H. Xu, J. Chen, M. Kang, J. Zou, L. J. Zhang, and Y. Shao, "Alterations in Meibomian Gland Characteristics and Tear Film-Related Parameters in Patients with Threatened Abortion: A New Diagnostic Index," *J. Clin. Ophthalmol.*, 2023.
[19] T. S. Roy, P. K. Saha, and S. Roy, "Efficacy of Vaginal Misoprostol Administered for Rapid Management of First Trimester Spontaneous Onset Incomplete Abortion in Comparison to Manual Vacuum Aspiration: A Randomised Clinical Trial," *J. Clin. Diagn. Res.*, vol. 17, no. 6, 2023.
[20] P. Bailey, L. Schacht, G. Pazienza, P. Seal, A. Crockett, and J. A. Justo, "Out with the Old, In with the New: A Review of the Treatment of Intrapartum Infections," *Curr. Infect. Dis. Rep.*, pp. 1-7, 2024.
[21] R. M. Marquardt, T. H. Kim, J. H. Shin, and J. W. Jeong, "Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?," *Int. J. Mol. Sci.*, vol. 20, no. 15, p. 3822, 2019.
[22] Y. M. Vasquez and F. J. DeMayo, "Role of Nuclear Receptors in Blastocyst Implantation," *Semin. Cell Dev. Biol.*, vol. 24, no. 10-12, pp. 724-735, 2013.
[23] J. Szekeres-Bartho and B. Polgar, "PIBF: The Double Edged Sword. Pregnancy and Tumor," *Am. J. Reprod. Immunol.*, vol. 64, no. 2, pp. 77-86, 2010.
[24] M. K. Lim, C. W. Ku, T. C. Tan, Y. H. J. Lee, J. C. Allen, and N. S. Tan, "Characterisation of Serum Progesterone and Progesterone-Induced Blocking Factor (PIBF) Levels Across Trimesters in Healthy Pregnant Women," *Sci. Rep.*, vol. 10, no. 1, p. 3840, 2020.
[25] M. Takeichi, "Functional Correlation Between Cell Adhesive Properties and Some Cell Surface Proteins," *J. Cell Biol.*, vol. 75, no. 2, pp. 464-474, 1977.
[26] S. H. M. Wong, C. M. Fang, L. H. Chuah, C. O. Leong, and S. C. Ngai, "E-Cadherin: Its Dysregulation in Carcinogenesis and Clinical Implications," *Crit. Rev. Oncol. Hematol.*, vol. 121, pp. 11-22, 2018.
[27] A. Ray, "Role of in Miscarriage," *Int. J. Gynecol. Obstet.*, vol. 3, no. 2, pp. 35, 2016.
[28] J. J. West and T. J. Harris, "Cadherin Trafficking for Tissue Morphogenesis: Control and Consequences," *Traffic*, vol. 17, no. 12, pp. 1233-1243, 2016.
[29] R. F. Savaris, J. L. Pedrini, R. Flores, G. Fabris, and C. G. Zettler, "Expression of Alpha 1 and Beta 3 Integrins Subunits in the Endometrium of Patients with Tubal Phimosis or Hydrosalpinx," *Fertil. Steril.*, vol. 85, no. 1, pp. 188-192, 2006.
[30] T. Csabai, E. Pallinger, A. F. Kovacs, E. Miko, Z. Bognar, and J. Szekeres-Bartho, "Altered Immune Response and Implantation Failure in Progesterone-Induced Blocking Factor-Deficient Mice," *Front. Immunol.*, vol. 11, p. 349, 2020.
[31] A. Elnaggar, A. H. Farag, M. E. Gaber, M. A. Hafeez, M. S. Ali, and A. M. Atef, "AlphaVBeta3 Integrin Expression Within Uterine Endometrium in Unexplained Infertility: A Prospective Cohort Study," *BMC Women's Health*, vol. 17, no. 1, pp. 1-9, 2017.